https://crinetics.com/press-releases/long-term-safety-efficacy-data-paltusotine-cbem/
Crinetics | New Long-Term Safety and Efficacy Data for Paltusotine to be Presented at CBEM
Driving the Next Generation of Endocrinology Care
https://palsonifyhcp.com/
PALSONIFY™ (paltusotine) FDA Approved for Acromegaly | HCP
Mar 23, 2026 - For US healthcare providers. FDA-approved PALSONIFY (paltusotine) is a once-daily oral for the first-line treatment of adults with acromegaly. See Prescribing...
fda approvedacromegalyhcp
https://africanewsguide.com/article/813184786-crinetics-to-present-new-research-on-paltusotine-atumelnant-and-unmet-needs-in-acromegaly-treatment-at-the-american-association-of-clinical
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly...
Africa News Guide is an online news publication focusing on the Africa: Following the news from Africa